This review examines the drug-like, cancer-suppressing, and food-based properties of paclitaxel, naringenin, and quercetin while emphasizing their therapeutic pathways and molecular functions. The chemotherapeutic agent paclitaxel stabilizes microtubules for cell cycle arrest, and naringenin alongside quercetin shows strong anticancer responses, antioxidant effects, and anti-inflammatory actions. The review explains how these compounds serve in cancer treatment together with their pharmacological mechanisms and it describes how novel drug delivery systems boost their therapeutic potential and bioavailability. Drug-testing evidence as well as patent documentation reveals increasing attention toward these drug compounds in cancer treatment. The three compounds paclitaxel, naringenin, and quercetin show great potential as cancer treatment and prevention agents while researchers continue to develop their clinical performance advanced through ongoing studies.
Chunarkar-PatilP, KaleemM, MishraR, et al.Anticancer drug discovery based on natural products: From computational approaches to clinical studies. Biomedicines, 2024; 12(1):201.
2.
AbboodRS, AlshammaryRA, Al-AttarMM. Overview of pathophysiology of cancer, types, causes, treatment. JPR, 2024; 24(4):17–24.
3.
VieiraIRS, Conte-JuniorCA. Nano-delivery systems for food bioactive compounds in cancer: Prevention, therapy, and clinical applications. Crit Rev Food Sci Nutr, 2024; 64(2):381–406.
4.
SharmaA, WairkarS. Flavonoids for treating pulmonary fibrosis: Present status and future prospects. Phytother Res, 2024; 38(9):4406–4423.
5.
BouyahyaA, BakrimS, AboulaghrasS, et al.Bioactive compounds from nature: Antioxidants targeting cellular transformation in response to epigenetic perturbations induced by oxidative stress. Biomed Pharmacother, 2024; 174:116432.
6.
Rajesh RU, SangeethaD. Therapeutic potentials and targeting strategies of quercetin on cancer cells: Challenges and future prospects. Phytomedicine, 2024; 133:155902.
7.
SatiP, SharmaE, DhyaniP, et al.Paclitaxel and its semi-synthetic derivatives: Comprehensive insights into chemical structure, mechanisms of action, and anticancer properties. Eur J Med Res, 2024; 29(1):90.
8.
AtokiAV, AjaPM, ShinkafiTS, et al.Naringenin: Its chemistry and roles in neuroprotection. Nutr Neurosci, 2024; 27(6):637–666.
9.
Carrillo-MartinezEJ, Flores-HernándezFY, Salazar-MontesAM, et al.Quercetin, a flavonoid with great pharmacological capacity. Molecules, 2024; 29(5):1000.
10.
SaccoJL, GomezEW. Epithelial–mesenchymal plasticity and epigenetic heterogeneity in cancer. Cancers (Basel), 2024; 16(19):3289.
11.
MazzagattiA, EngelJL, LyP. Boveri and beyond: Chromothripsis and genomic instability from mitotic errors. Mol Cell, 2024; 84(1):55–69.
12.
XiongF, ZhangY, LiT, et al.A detailed overview of quercetin: Implications for cell death and liver fibrosis mechanisms. Front Pharmacol, 2024; 15:1389179.
13.
LuoM, WangY-M, ZhaoF-K, LuoY. Recent advances in nanomaterial‐mediated cell death for cancer therapy. Adv Healthc Mater, 2025; 14(1):e2402697.
14.
LiuS, ZhongM, WuH, et al.Potential beneficial effects of naringin and naringenin on Long COVID—A review of the literature. Microorganisms, 2024; 12(2):332.
15.
MengG, MengL, XuY. Naringin protects against diabetic cataracts in rats by modulating oxidative stress and inflammation. Archives of Biological Sciences, 2024(00):39.
16.
TyagiJL, GuptaP, GhateMM, et al.Assessing the synergistic potential of bacteriophage endolysins and antimicrobial peptides for eradicating bacterial biofilms. Arch Microbiol, 2024; 206(6):272–214.
17.
SopjaniM, FalcoF, ImpellitteriF, et al.Flavonoids derived from medicinal plants as a COVID‐19 treatment. Phytother Res, 2024; 38(3):1589–1609.
18.
MouffoukC, MouffoukS, MouffoukS, et al.Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2). Eur J Pharmacol, 2021; 891:173759.
19.
CaiJ, WenH, ZhouH, et al.Naringenin: A flavanone with anti-inflammatory and anti-infective properties. Biomed Pharmacother, 2023; 164:114990.
20.
Świątek SieniawskaE, Maciejewska-TurskaM. ŁFlavonoids as potential inhibitors targeting SARS-CoV-2. In: Traditional Medicines and Natural Products as Preventive and Therapeutic Agents Against COVID-19. Elsevier; 2025. pp. 105–29.
21.
Di CarloE, SorrentinoC. Oxidative stress and age-related tumors. Antioxidants (Basel), 2024; 13(9):1109.
22.
DadaA, da SilvaRdCV, ZanovelloM, et al.Comparative analysis of the protective effect of naringenin on cardiovascular parameters of normotensive and hypertensive rats subjected to the myocardial infarction model. Pharmaceuticals (Basel), 2024; 17(10):1324.
23.
WangD, ZhouY, HuaL, et al.The role of the natural compound naringenin in AMPK-mitochondria modulation and colorectal cancer inhibition. Phytomedicine, 2024; 131:155786.
24.
HouglumJE, HarrelsonGL, SeefeldtTM. Drugs for treating gastrointestinal disorders. In: Principles of Pharmacology for Athletic Trainers. Routledge; 2024. pp. 186–209.
25.
ZenjanabMK, AlimohammadvandS, DoustmihanA, et al.Paclitaxel for breast cancer therapy: A review on effective drug combination modalities and nano drug delivery platforms. J Drug Deliv Sci Technol, 2024:105567.
26.
ChaithanyaA, SaravananR, SebastinV, SeethangoliK. Approaches and advancements in the improvement of quercetin bioavailability. YUGATO, 2024.
27.
BhattP, KumarV, MalikMK, KumarT. Citrus flavonoids: recent advances and future perspectives on preventing cardiovascular diseases. In: The Flavonoids. Wiley; 2024. pp. 131–52.
28.
IslamMR, Al ImranMIK, ZehraviM, et al.Targeting signaling pathways in neurodegenerative diseases: Quercetin’s cellular and molecular mechanisms for neuroprotection. Anim Models Exp Med, 2025.
29.
WuX, WuH, ZhongM, et al.Epigenetic regulation by naringenin and naringin: A literature review focused on the mechanisms underlying its pharmacological effect. Fitoterapia, 2025; 181:106353.
30.
ChengY, FengS, ShengC, et al.Nobiletin from citrus peel: A promising therapeutic agent for liver disease—pharmacological characteristics, mechanisms, and potential applications. Front Pharmacol, 2024; 15:1354809.
31.
Unnikrishnan MeenakshiD, NardeGK, AhujaA, et al.Therapeutic applications of nanoformulated resveratrol and quercetin phytochemicals in colorectal cancer—an updated review. Pharmaceutics, 2024; 16(6):761.
32.
KumarG, MullickP, AndugulapatiSB, et al.Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations. J Drug Deliv Sci Technol, 2024; 95:105614.
33.
ParkD, LeeSJ, ParkJ-W. Aptamer-Based smart targeting and spatial trigger–response drug-delivery systems for anticancer therapy. Biomedicines, 2024; 12(1):187.
34.
LiuJ, WangP, HuangB, et al.Effective suppression of triple negative breast cancer by paclitaxel nanoparticles conjugated with transmembrane TNF-α monoclonal antibody. Int J Pharm, 2022; 624:121969.
35.
ZhouJ, WanS, WuY, et al.Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer. Biomed Pharmacother, 2024; 177:117102.
36.
PiC, ZhaoW, ZengM, et al.Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo. Drug Deliv, 2022; 29(1):1878–1891.
37.
PramualS, LirdprapamongkolK, AtjanasuppatK, et al.PLGA-lipid hybrid nanoparticles for overcoming paclitaxel tolerance in anoikis-resistant lung cancer cells. Molecules, 2022; 27(23):8295.
38.
ChaudhariD, KucheK, YadavV, et al.Exploring paclitaxel-loaded adenosine-conjugated PEGylated PLGA nanoparticles for targeting triple-negative breast cancer. Drug Deliv Transl Res, 2023; 13(4):1074–1087.
39.
SalveR, KumarP, ChaudhariBP, et al.Aptamer tethered bio-responsive mesoporous silica nanoparticles for efficient targeted delivery of paclitaxel to treat ovarian cancer cells. J Pharm Sci, 2023; 112(5):1450–1459.
40.
MenonS, JayakodiS, YadavKK, et al.Preparation of paclitaxel-encapsulated bio-functionalized selenium nanoparticles and evaluation of their efficacy against cervical cancer. Molecules, 2022; 27(21):7290.
41.
SongY, BugadaL, LiR, et al.Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice. Sci Transl Med, 2022; 14(643):eabl3649.
42.
HouL, ZhongT, ChengP, et al.Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer. Front Bioeng Biotechnol, 2022; 10:938662.
43.
YakatiV, VangalaS, MadamsettyVS, et al.Enhancing the anticancer effect of paclitaxel by using polymeric nanoparticles decorated with colorectal cancer targeting CPKSNNGVC-peptide. J Drug Deliv Sci Technol, 2022; 68:103125.
44.
SinghS, PalK. Exploration of polydopamine capped bimetallic oxide (CuO-NiO) nanoparticles inspired by mussels for enhanced and targeted paclitaxel delivery for synergistic breast cancer therapy. Appl Surf Sci, 2023; 626:157266.
45.
Atlı ŞekeroğluZ, ŞekeroğluV, AydınB, et al.Cerium oxide nanoparticles exert antitumor effects and enhance paclitaxel toxicity and activity against breast cancer cells. J Biomed Mater Res B Appl Biomater, 2023; 111(3):579–589.
46.
VemuriSK, HalderS, BanalaRR, et al.Modulatory effects of biosynthesized gold nanoparticles conjugated with curcumin and paclitaxel on tumorigenesis and metastatic pathways—in vitro and in vivo studies. Int J Mol Sci, 2022; 23(4):2150.
47.
LuM, WangS, KhineYY, et al.Dual drug delivery system of RAPTA-C and paclitaxel based on fructose coated nanoparticles for metastatic cancer treatment. Biochem Biophys Res Commun, 2023; 640:134–141.
48.
ZenjanabMK, PakchinPS, FathiM, et al.Niosomes containing paclitaxel and gold nanoparticles with different coating agents for efficient chemo/photothermal therapy of breast cancer. Biomed Mater, 2024; 19(3); doi: 10.1088/1748-1605X/ad2ed5
49.
TunçT, HepokurC, Kari PerA. Synthesis and characterization of paclitaxel‐loaded silver nanoparticles: Evaluation of cytotoxic effects and antimicrobial activity. Bioinorg Chem Appl, 2024; 2024(1):9916187.
50.
McFaddenM, SinghSK, KinnelB, et al.The effect of paclitaxel-and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer. J Ovarian Res, 2023; 16(1):220.
51.
Al-HumaidiRB, FayedB, ShakartallaSB, et al.Optimum inhibition of MCF-7 breast cancer cells by efficient targeting of the macropinocytosis using optimized paclitaxel-loaded nanoparticles. Life Sci, 2022; 305:120778.
52.
XiaoD, HuangY, HuangS, et al.Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer. Colloids Surf B Biointerfaces, 2022; 212:112366.
53.
YinH, YanQ, LiuY, et al.Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment. RSC Adv, 2022; 12(50):32534–32551.
54.
HaoD, MengQ, JiangB, et al.Hypoxia-activated PEGylated paclitaxel prodrug nanoparticles for potentiated chemotherapy. ACS Nano, 2022; 16(9):14693–14702.
55.
PitchikaS, SahooSK. Paclitaxel and Lapatinib dual-loaded chitosan-coated PLGA nanoparticles enhance cytotoxicity by circumventing MDR1-mediated trastuzumab resistance in HER2-positive breast cancers: In-vitro and in-vivo studies. J Drug Deliv Sci Technol, 2022; 73:103445.
56.
ZhangW, XuY, ShiX, et al.Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer. Nanomedicine (Lond), 2022; 17(10):683–694.
57.
ChittineediP, PandrangiSL, Neira MosqueraJA, et al.Aqueous Nyctanthes arbortristis and doxorubicin conjugated gold nanoparticles synergistically induced mTOR-dependent autophagy-mediated ferritinophagy in paclitaxel-resistant breast cancer stem cells. Front Pharmacol, 2023; 14:1201319.
58.
HuX, YuL, BianY, et al.Paclitaxel-loaded tumor cell-derived microparticles improve radiotherapy efficacy in triple-negative breast cancer by enhancing cell killing and stimulating immunity. Int J Pharm, 2023; 632:122560.
59.
CuiX, ZhangF, ZhaoY, et al.A novel ligand-modified nanocomposite microparticles improved efficiency of quercetin and paclitaxel delivery in non-small cell lung cancer. Drug Deliv, 2022; 29(1):3123–3133.
60.
HuangF, YangS, WangH, et al.pH-responsive PLGA/gelatin porous microspheres containing paclitaxel used for inhibition of cancer cell proliferation. J Drug Deliv Sci Technol, 2023; 86:104735.
61.
SharmaNR, LoSK, HendifarA, et al.Response of locally advanced pancreatic cancer to intratumoral injection of large surface area microparticle paclitaxel: Initial report of safety and clinical outcome. Pancreas, 2023; 52(3):e179–e187.
62.
LiuY, MaW, ZhouP, et al.In situ administration of temperature-sensitive hydrogel composite loading paclitaxel microspheres and cisplatin for the treatment of melanoma. Biomed Pharmacother, 2023; 160:114380.
63.
WuM-Y, KaoI-F, FuC-Y, YenS-K. Effects of adding chitosan on drug entrapment efficiency and release duration for paclitaxel-loaded hydroxyapatite–gelatin composite microspheres. Pharmaceutics, 2023; 15(8):2025.
64.
PrasadNK, ShomeR, BiswasG, et al.Transport behavior of commercial anticancer drug protein-bound paclitaxel (Paclicad) in a micron-sized channel. Langmuir, 2022; 38(6):2014–2025.
65.
LiangM, LiF, WangY, et al.Woven vascular stent-grafts with surface modification of silk fibroin-based paclitaxel/metformin microspheres. Bioengineering (Basel), 2023; 10(4):399.
66.
MottolaS, De MarcoI. Designing microparticles of luteolin and naringenin in different carriers via supercritical antisolvent process. Polymers (Basel), 2024; 16(24):3600.
67.
ElnawasanyS, HaggagYA, ShalabySM, et al.Anti-cancer effect of nano-encapsulated boswellic acids, curcumin and naringenin against HepG-2 cell line. BMC Complementary Med Ther, 2023; 23(1):270.
68.
YıldırımM, AcetÖ, YetkinD, et al.Anti-cancer activity of naringenin loaded smart polymeric nanoparticles in breast cancer. J Drug Deliv Sci Technol, 2022; 74:103552.
69.
ShengQ, HouX, WangY, et al.Naringenin microsphere as a novel adjuvant reverses colistin resistance via various strategies against multidrug-resistant Klebsiella pneumoniae infection. J Agric Food Chem, 2022; 70(51):16201–16217.
70.
ŞahinD, ÇağlarEŞ, BoranT, et al.Development, characterization of naringenin-loaded promising microemulsion formulations, and demonstration of anti-aging efficacy by in vitro enzyme activity and gene expression. J Drug Deliv Sci Technol, 2023; 84:104422.
71.
MaY, YangJ, ZhangY, et al.Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: In vitro and in vivo evaluation. Drug Deliv, 2022; 29(1):111–127.
72.
MdS, AbdullahS, AwanZA, AlhakamyNA. Smart oral pH-responsive dual layer nano-hydrogel for dissolution enhancement and targeted delivery of naringenin using protein-polysaccharides complexation against colorectal cancer. J Pharm Sci, 2022; 111(11):3155–3164.
73.
AhmadA, PrakashR, KhanMS, et al.Enhanced antioxidant effects of naringenin nanoparticles synthesized using the high-energy ball milling method. ACS Omega, 2022; 7(38):34476–34484.
74.
PareekA, KothariR, PareekA, et al.Development of a new inhaled swellable microsphere system for the dual delivery of naringenin-loaded solid lipid nanoparticles and doxofylline for the treatment of asthma. Eur J Pharm Sci, 2024; 193:106642.
75.
AlhalmiA, AminS, RalliT, et al.Therapeutic role of naringin in cancer: Molecular pathways, synergy with other agents, and nanocarrier innovations. Naunyn-Schmiedeberg’s Arch Pharmacol, 2025; 398(4):3595–3615.
76.
AlmoallimHS, AljawdahHM, BharathiM, et al.Fabrication of ibuprofen/naringenin-coloaded into zein/sodium caseinate nanoparticles: Evaluation of antiproliferative activity and apoptosis induction in liver cancer cells. J Biomater Sci Polym Ed, 2024; 35(17):2703–2722.
77.
NguyenHT, HenselA, GoycooleaFM. Chitosan/cyclodextrin surface-adsorbed naringenin-loaded nanocapsules enhance bacterial quorum quenching and anti-biofilm activities. Colloids Surf B Biointerfaces, 2022; 211:112281.
78.
WangX, ZhangX, LiuZ, et al.Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition. Int J Biochem Cell Biol, 2024; 169:106557.
79.
MohamedEE, Abdel-MoneimA, AhmedOM, et al.Anticancer activity of a novel naringin–dextrin nanoformula: Preparation, characterization, and in vitro induction of apoptosis in human hepatocellular carcinoma cells by inducing ROS generation, DNA fragmentation, and cell cycle arrest. J Drug Deliv Sci Technol, 2022; 75:103677.
80.
GuoM, HeZ, JinZ, et al.Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages. Nano Res, 2023; 16(1):925–937.
81.
MirzaeiM, EbrahimipourSY, MohamadiM, ShamspurT. Targeted drug delivery of quercetin to breast cancer cells using a modified SBA-15 mesoporous nanostructure. J Clust Sci, 2024; 35(5):1345–1358.
82.
HomayoonfalM, AminianfarA, AsemiZ, YousefiB. Application of nanoparticles for efficient delivery of quercetin in cancer cells. Curr Med Chem, 2024; 31(9):1107–1141.
83.
NajafiM, KhoddamZ, MasnaviM, et al.Physicochemical and in vitro characterization of agarose-based nanocarriers incorporated with graphene quantum dots/α-Fe2O3 for targeted drug delivery of quercetin to liver cancer treatment. Mater Chem Phys, 2024; 320:129333.
84.
BadrlooMA, PourmadadiM, AbdoussM, et al.Ameliorating quercetin delivery in cancer therapy with polyvinyl alcohol/halloysite/starch nanocomposite. Ind Crops Prod, 2024; 218:118939.
85.
NajafiM, PourmadadiM, AbdousM, et al.Formulation of double nanoemulsions based on pH-sensitive carboxymethyl cellulose/starch copper doped carbon quantum dots for quercetin controlled release. J Mol Liq, 2024; 400:124543.
86.
ElbeltagiS, Abdel ShakorAB, AlharbiH, et al.Synergistic effects of quercetin-loaded CoFe2O4@ liposomes regulate DNA damage and apoptosis in MCF-7 cancer cells: Based on biophysical magnetic hyperthermia. Drug Dev Ind Pharm, 2024; 50(6):561–575.
87.
MohamedJMM, AhmadF, El-SherbinyM, et al.Optimization and characterization of quercetin-loaded solid lipid nanoparticles for biomedical application in colorectal cancer. Cancer Nano, 2024; 15(1):16.
88.
GhalehkhondabiV, SoleymaniM, FazlaliA. Synthesis of quercetin-loaded hyaluronic acid-conjugated pH/redox dual-stimuli responsive poly(methacrylic acid)/mesoporous organosilica nanoparticles for breast cancer targeted therapy. Int J Biol Macromol, 2024; 263(Pt 1):130168.
89.
ShenB, ZhuY, WangF, et al.Fabrication and in vitro/vivo evaluation of quercetin nanocrystals stabilized by glycyrrhizic acid for liver targeted drug delivery. Int J Pharm X, 2024; 7:100246.
90.
AslAM, KalaeeM, AbdoussM, HomamiSS. Novel targeted delivery of quercetin for human hepatocellular carcinoma using starch/polyvinyl alcohol nanocarriers based hydrogel containing Fe2O3 nanoparticles. Int J Biol Macromol, 2024; 257(Pt 2):128626.
91.
PourmadadiM, AbdoussH, MemarzadehA, et al.Innovative chitosan-polyacrylic acid-MoS2 nanocomposite for enhanced and pH-responsive quercetin delivery. Mater Today Commun, 2024; 39:108724.
92.
LiaoR, ZhangY, MaoW. Functionalized graphene oxide NPs as a nanocarrier for drug delivery system in quercetin/lurbinectedin as dual sensitive therapeutics for A549 lung cancer treatment. Heliyon, 2024; 10(11):e31212.
93.
LuQ, GaoW, ChenZ, et al.Co-delivery of paclitaxel/atovaquone/quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles. Int J Pharm, 2024; 655:124028.
94.
ZygouriP, TsiodoulosG, AngelidouM, et al.Graphene oxide and oxidized carbon nanodiscs as biomedical scaffolds for the targeted delivery of quercetin to cancer cells. Nanoscale Adv, 2024; 6(11):2860–2874.
95.
LiJ, DuQ, WanJ, et al.Improved synergistic anticancer action of quercetin and tamoxifen citrate supported by an electrospun complex nanostructure. Mater Des, 2024; 238:112657.
96.
ChangC-h, HanD-e, JiY-y, et al.Folate-chitosan coated quercetin liposomes for targeted cancer therapy. Curr Pharm Biotechnol, 2024; 25(7):924–935.
97.
PaleiNN, MounikaG, MohantaBC, RajangamJ. Quercetin and morin dual drug-loaded nanostructured lipid carriers: Formulation and in vitro cytotoxicity study on MCF7 breast cancer cells. J Dispersion Sci Technol, 2024; 45(11):2146–2154.
98.
PourmadadiM, ShabestariSM, AbdoussH, et al.Green synthesis of pH-sensitive carboxymethyl cellulose/agarose/carbon quantum dots nanocarriers for quercetin delivery to A549 lung cancer using an emulsification method. BioNanoSci, 2024; 14(4):4570–4584.
99.
MohammadiZS, PourmadadiM, AbdoussM, et al.pH-sensitive polyacrylic acid/Fe3O4@SiO2 hydrogel nanocomposite modified with agarose for controlled release of quercetin. Inorg Chem Commun, 2024; 163:112338.
100.
ElbeltagiS, SaeediAM, EldinZE, et al.Biosynthesis, characterization, magnetic hyperthermia, and in vitro toxicity evaluation of quercetin-loaded magnetoliposome lipid bilayer hybrid system on MCF-7 breast cancer. Biochim Biophys Acta Gen Subj, 2024; 1868(3):130543.
101.
TahamtanS, ShamsabadipourA, PourmadadiM, et al.Biocompatible chitosan/starch/graphene quantum dots/titanium dioxide nanocomposite: A stimuli-responsive, porous nanocarrier for prolonged quercetin delivery in lung cancer treatment. BioNanoSci, 2024; 14(3):2491–2508.
102.
Nguyen-HuuA-M, LeNTT, Vo DoMH, et al.Development and characterization of quercetin-loaded polymeric liposomes with gelatin–poly(ethylene glycol)–folic acid coating to increase their long-circulating and anticancer activity. ACS Appl Bio Mater, 2024; 7(7):4454–4470.
103.
ZhouL, LiY, LinZ, et al.Biotin-modified hyaluronic acid double-target nanoparticles for quercetin and IR780 delivery: Fabrication, characterization, and biological properties. Arab J Chem, 2024; 17(2):105520.
104.
DingL, DangS, SunM, et al.Quercetin induces ferroptosis in gastric cancer cells by targeting SLC1A5 and regulating the p-Camk2/p-DRP1 and NRF2/GPX4 axes. Free Radic Biol Med, 2024; 213:150–163.
105.
ParsaeiM, AkhbariK, TylianakisE, et al.Effects of fluorinated functionalization of linker on quercetin encapsulation, release and HeLa cell cytotoxicity of Cu‐based MOFs as smart pH‐stimuli nanocarriers. Chem Eur J, 2024; 30(1):e202301630.
106.
KalamMA, AliR, AlhowyanA, et al.Quercetin-loaded transliposomal gel for effective management of skin cancer: In vitro and cell line efficacy studies. J Drug Deliv Sci Technol, 2024; 96:105659.
107.
Jamshidi-MouselouMS, HashemiA, Jamshidi-MouselouMS, et al.Application of quercetin and its novel formulations in the treatment of malignancies of central nervous system: An updated review of current evidence based on molecular mechanisms. Curr Med Chem, 2024; 31(26):4180–4198.
108.
NguyenH-VT, PhamSN, MirzaeiA, et al.Surface modification of ZIF-8 nanoparticles by hyaluronic acid for enhanced targeted delivery of quercetin. Colloids Surf A Physicochem Eng Asp, 2024; 696:134288.
ElbeltagiS, AlfassamHE, SaeediAM, et al.A novel quercetin-loaded NiFe2O4@liposomes hybrid biocompatible as a potential chemotherapy/hyperthermia agent and cytotoxic effects on breast cancer cells. J Drug Deliv Sci Technol, 2024; 91:105203.
111.
SeddighiY, PourmadadiM, AbdoussM, et al.In vitro evaluation and characterization of double emulsion based on polyvinylpyrrolidone/agarose/ZIF-8 hydrogel nanocomposite platform for quercetin delivery to breast cancer cells. BioNanoSci, 2024; 14(3):3153–3167.
112.
LiuY, LiY, JiangY, et al.Quercetin promotes apoptosis of gastric cancer cells through the EGFR‐ERK signaling pathway. J Food Biochem, 2024; 2024(1):1–23.
113.
MohammadipoorN, NaiebiR, MazhariSA, et al.Improved therapy for clear cell renal cell carcinoma: Beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance. Mol Biol Rep, 2024; 51(1):379.
114.
ZhuJ, ChengX, NaumovskiN, et al.Epigenetic regulation by quercetin: A comprehensive review focused on its biological mechanisms. Crit Rev Food Sci Nutr, 2025; 65(4):627–646.
115.
JiangY, XingM, SunJ, et al.Construction of resveratrol and quercetin nanoparticles based on folic acid targeted Maillard products between Jiuzao glutelin isolate and carboxymethyl chitosan: Improved stability and function. Food Chem, 2024; 450:139296.
116.
LiS-F, HuT-G, WuH. Development of quercetin-loaded electrospun nanofibers through shellac coating on gelatin: Characterization, colon-targeted delivery, and anticancer activity. Int J Biol Macromol, 2024; 277(Pt 2):134204.
117.
KhanH, UllahH, MartorellM, et al.Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin Cancer Biol, 2021; 69:200–211. Elsevier.
118.
VahedSZ, SalehiR, DavaranS, SharifiS. Liposome-based drug co-delivery systems in cancer cells. Materials Science and Engineering: C, 2017; 71:1327–1341.
119.
HamzaA, MylarapuA, KrishnaKV, KumarDS. An insight into the nutritional and medicinal value of edible mushrooms: A natural treasury for human health. J Biotechnol, 2024; 381:86–99.
120.
JadhavPV, PrasathNJ, GajbhiyeSG, et al.Empowering the battle: Bioenhancers as allies against cancer drug resistance. Curr Pharm Biotechnol, 2024; 25(12):1552–1563.
121.
HekmatA, HaertléT, LeblancRM, et al.A review on interaction of nanomaterials of Group-XIV (G14) elements of the periodic table with proteins and DNA: Applications in biotechnology and pharmacy. BioNanoSci, 2024; 14(2):1978–2003.
